Showing results (81-90 of 2,576) with videos related to

Sort By:
Pageof 258
Molecular Oncology|December 17, 2021
p53 mutations define the chromatin landscape to confer drug tolerance in pancreatic cancerCarlotta Zampieri, Emanuele Panatta, Vincenzo Corbo, et al.
Molecular Oncology|January 21, 2022
Digital multiplexed analysis of circular RNAs in FFPE and fresh non-small cell lung cancer specimensCarlos Pedraz-Valdunciel, Stavros Giannoukakos, Nicolas Potie, et al.
Molecular Oncology|November 18, 2021
Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivityYing Z Mazzu, YuRou Liao, Subhiksha Nandakumar, et al.
Molecular Oncology|March 10, 2021
The levels of soluble cMET ectodomain in the blood of patients with ovarian cancer are an independent prognostic biomarkerDaniel Martin Klotz, Theresa Link, Maren Goeckenjan, et al.
Molecular Oncology|November 2, 2022
Post-prostatic-massage urine exosomes of men with chronic prostatitis/chronic pelvic pain syndrome carry prostate-cancer-typical microRNAs and activate proto-oncogenesLaura Schneider, Temuujin Dansranjav, Elena Neumann, et al.
Molecular Oncology|October 12, 2022
Heterogeneous RNA editing and influence of ADAR2 on mesothelioma chemoresistance and the tumor microenvironmentAnanya Hariharan, Weihong Qi, Hubert Rehrauer, et al.
Molecular Oncology|February 19, 2021
EWI-2 controls nucleocytoplasmic shuttling of EGFR signaling molecules and miRNA sorting in exosomes to inhibit prostate cancer cell metastasisChenying Fu, Qing Zhang, Ani Wang, et al.
Molecular Oncology|March 6, 2021
Ferroptosis inducer erastin sensitizes NSCLC cells to celastrol through activation of the ROS-mitochondrial fission-mitophagy axisMing Liu, Yumei Fan, Danyu Li, et al.
Molecular Oncology|December 23, 2021
Clinical significance of FAT1 gene mutation and mRNA expression in patients with head and neck squamous cell carcinomaSu Il Kim, Seon Rang Woo, Joo Kyung Noh, et al.
Molecular Oncology|December 23, 2021
Cancer outcome research - a European challenge Part II: Opportunities and prioritiesMette Kalager, Hans-Olov Adami, Paul W Dickman, et al.
Pageof 258